Biotech: Lonza Ties with Cellectis to Improve Cell Lines

19:22 PM | June 8, 2010 | Alex Scott

Lonza says it has agreed a deal with Cellectis (Paris; France), a biotech firm involved in genome customization, to develop and commercialize bioengineered cell lines for manufacturing biologic drugs...